Xponance’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$851K Buy
1,626
+163
+11% +$77.9K 0.01% 800
2025
Q4
$852K Buy
1,463
+3
+0.2% +$1.53K 0.01% 738
2025
Q3
$670K Buy
1,460
+152
+12% +$56.7K 0.01% 858
2025
Q2
$396K Sell
1,308
-51
-4% -$15.2K ﹤0.01% 1035
2025
Q1
$450K Buy
1,359
+91
+7% +$29.9K ﹤0.01% 971
2024
Q4
$391K Buy
1,268
+113
+10% +$31.8K ﹤0.01% 1032
2024
Q3
$245K Buy
1,155
+38
+3% +$9.72K ﹤0.01% 1155
2024
Q2
$313K Buy
1,117
+224
+25% +$53.3K ﹤0.01% 1046
2024
Q1
$238K Buy
893
+2
+0.2% +$471 ﹤0.01% 1132
2023
Q4
$206K Buy
+891
New +$156K ﹤0.01% 1150
2023
Q1
Sell
-729
Closed -$212K 1249
2022
Q4
$212K Buy
+729
New +$71.3K ﹤0.01% 1113

Other funds holding MDGL